Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Exp Parasitol
2010 Aug 01;1254:342-7. doi: 10.1016/j.exppara.2010.02.016.
Show Gene links
Show Anatomy links
Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts.
Fieck A
,
Hurwitz I
,
Kang AS
,
Durvasula R
.
???displayArticle.abstract???
The parasite Trypanasoma cruzi is responsible for Chagas disease and its triatomine vector, Rhodnius prolixus, has a symbiotic relationship with the soil bacterium, Rhodococcus rhodnii. R. rhodnii that was previously genetically engineered to produce the anti-microbial peptide, cecropin A was co-infected with T. cruzi into R. prolixus resulting in clearance of the infectious T. cruzi in 65% of the vectors. Similar anti-microbial peptides have been isolated elsewhere and were studied for differential toxicity against T. cruzi and R. rhodnii. Of the six anti-microbial peptides tested, apidaecin, magainin II, melittin, and cecropin A were deemed potential candidates for the Chagas paratransgenic system as they were capable of killing T.cruzi at concentrations that exhibit little or no toxic effects on R. rhodnii. Subsequent treatments of T. cruzi with these peptides in pair-wise combinations resulted in synergistic killing, indicating that improvement of the 65% parasite clearance seen in previous experiments may be possible utilizing combinations of different anti-microbial peptides.
Asthana,
Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity.
2004, Pubmed
Asthana,
Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity.
2004,
Pubmed
Bern,
Evaluation and treatment of chagas disease in the United States: a systematic review.
2007,
Pubmed
Brener,
Biology of Trypanosoma cruzi.
1973,
Pubmed
Bulet,
Antimicrobial peptides in insects; structure and function.
1999,
Pubmed
Casteels,
Apidaecins: antibacterial peptides from honeybees.
1989,
Pubmed
Castle,
Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets.
1999,
Pubmed
Chiou,
Molecular cloning and characterization of cDNA of penaeidin-like antimicrobial peptide from tiger shrimp (Penaeus monodon).
2005,
Pubmed
Costa,
Chagas Disease Control Programme in Brazil: a study of the effectiveness of 13 years of intervention.
1998,
Pubmed
Dias,
The impact of Chagas disease control in Latin America: a review.
2002,
Pubmed
Durvasula,
Expression of a functional antibody fragment in the gut of Rhodnius prolixus via transgenic bacterial symbiont Rhodococcus rhodnii.
1999,
Pubmed
Durvasula,
Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria.
1997,
Pubmed
HARINGTON,
Studies on Rhodnius prolixus: growth and development of normal and sterile bugs, and the symbiotic relationship.
1960,
Pubmed
Habermann,
Bee and wasp venoms.
1972,
Pubmed
Hara,
Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori.
1995,
Pubmed
Hemmi,
Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori.
2002,
Pubmed
Schofield,
Control of Chagas' disease vectors.
1985,
Pubmed
White,
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
1996,
Pubmed
Zasloff,
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
1987,
Pubmed
,
Xenbase
